Optimistic Buy Rating for Immunic Driven by Promising Trials and Market Opportunities for VidoCa
Leerink Partners analyst Faisal Khurshid reiterated a Buy rating on Immunic (IMUX – Research Report) on November 7 and set a price target ...
TechCrunch1mon
How a medtech market opportunity is shaping up for wearable neurotech
The scope of the market opportunity is another angle here that’s exciting investors. There are many potential therapeutic applications for neurotech wearables — with depression just one of ...
Buy Rating for Novo Nordisk: Strategic Growth and Market Opportunities Amid Supply Challenges
Analyst Michael Nedelcovych from TD Cowen maintained a Buy rating on Novo Nordisk (NVO – Research Report) and keeping the price target at ...